Cipla stock jumps to all-time high; Nuvama raises target price, sees 18% upside
Cipla is aiming to transition from a pure-play pharma company to an integrated health player, per analysts.
Source: moneycontrol.com
Cipla Stock News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cipla Stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cipla Stock Today - Breaking & Trending Today
Choice Broking's Sumeet Bagadia lists Cipla as top 'Valentine's Day 2024 Pick'; here's why
Sumeet Bagadia of Choice Broking has chosen Cipla as his ‘Valentine's Day 2024 Pick’. Bagadia has recommended a ‘Buy’ on the pharma stock at ₹1,450 and up to ₹1,415 for a target price of ₹1,600 to ₹1,660.
Source: livemint.com
Cipla's Samina Hamied steps down citing personal commitments
Samina is the niece of Cipla non-executive chairman YK Hamied, and daughter of his brother and non-executive vice-chairman, MK Hamied. The company said she would continue as a non-executive director.
Source: businesstoday.in
cipla share price: Cipla shares jump 7%, hit 52-week high on strong Q3 earnings
On Monday, Cipla reported a 31.8% year-on-year (YoY) jump in its October-December quarter consolidated net profit at Rs 1,056 crore. It was Rs 801 crore in the year-ago period.
Source: indiatimes.com
Cipla's US-arm recalls drug due to improper seal, could have 'life threatening' effects; shares fall
The product, Vigabatrin for oral solution, USP 500mg, is used for the treatment of refractory complex partial seizures as adjunctive therapy in patients 2 years of age and older.
Source: moneycontrol.com